BiotechTV

BiotechTV

Share this post

BiotechTV
BiotechTV
Creyon Bio today announced a collaboration to help Lilly use its AI-powered oligo engineering platform and aptamer-based delivery approach to discover and develop therapies in a range of diseases

Creyon Bio today announced a collaboration to…

BiotechTV
Apr 29

Share this post

BiotechTV
BiotechTV
Creyon Bio today announced a collaboration to help Lilly use its AI-powered oligo engineering platform and aptamer-based delivery approach to discover and develop therapies in a range of diseases

Recently named CEO Serge Messerlian describes the platform behind this deal, which came with an upfront payment/investment of $13 million.

Listen →
Comments
User's avatar
© 2025 BiotechTV
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share